CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
3-DXd will be evaluated in participants with metastatic or unresectable NSCLC with EGFR activating mutation or squamous or non-squamous NSCL...
Phase 1
Duarte, California, United States and 36 other locations
type of side effects may occur with the drug treatment. It will also measure the levels of drug in the body and preliminarily assess its anti-cancer...
Phase 1, Phase 2
Whittier, California, United States of America and 124 other locations
in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...
Phase 3
Los Angeles, California, United States and 210 other locations
with separate sub- studies. Sub-study 1 includes participants with non-small cell lung cancer (NSCLC) wi...
Phase 2
Los Angeles, California, United States of America and 61 other locations
HCC is a common cancer worldwide and a leading cause of cancer-related death. Lung cancer is the most frequently ...
Phase 1
Los Angeles, California, United States and 21 other locations
participants with unresectable or metastatic melanoma or advanced non-small-cell lung cancer (NSCLC)....
Phase 1, Phase 2
Los Angeles, California, United States and 10 other locations
This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...
Phase 2
Los Angeles, California, United States and 123 other locations
purpose of this study is to evaluate how well Rina-S works against lung cancer.The treatment in this study is Rina-S monotherapy (b...
Phase 2
Fountain Valley, California, United States and 21 other locations
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...
Phase 3
Duarte, California, United States and 230 other locations
This is a Phase II, multi-center, open-label platform study evaluating novel combination treatment options in participants with locally advanced or m...
Phase 2
Santa Monica, California, United States and 82 other locations
Clinical trials
Research sites
Resources
Legal